Prospera Financial Services’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-76
Closed -$4K 1094
2022
Q2
$4K Sell
76
-126
-62% -$6.92K ﹤0.01% 1476
2022
Q1
$13K Buy
+202
New +$13.3K ﹤0.01% 1915
2021
Q4
Sell
-2,944
Closed -$265K 879
2021
Q3
$265K Buy
+2,944
New +$268K 0.01% 693
2021
Q2
Sell
-2,220
Closed -$214K 805
2021
Q1
$214K Buy
+2,220
New +$229K 0.01% 705

Other funds holding FLGT

Prospera Financial Services's FLGT Position: Q3 2022 in Review

Prospera Financial Services sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 76 shares — an estimated $4K sold.

Prospera Financial Services first reported a position in FLGT in Q1 2021 and held it in 4 quarters. The position peaked at $265K in Q3 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Prospera Financial Services reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 76 Fulgent Genetics shares in Q3 2022, an estimated $4K.
  • Prospera Financial Services first reported a position in Fulgent Genetics in Q1 2021 and held it in 4 quarters.
  • Prospera Financial Services's Fulgent Genetics position peaked at $265K in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.